Saturday, December 6, 2025

THE FIRST WEATHER FORECAST: North Korea’s New ‘Supercomputer’ Predicts It Will Rain Today

North Korea launches an AI-integrated weather forecasting system to enhance disaster preparedness after last summer's severe floods.

SM Entertainment’s New Girl Group Hearts2Hearts Preps for Global Debut with ‘The Chase’

SM Entertainment's girl group Hearts2Hearts debuts with single "The Chase," featuring the emotional B-side "Butterflies."

Samsung Display Signals Readiness to Supply Foldable OLEDs, MicroLEDs to Apple and Tesla

Samsung Display's CEO Lee Chung discusses next-gen displays for Apple and Tesla, addressing tariffs' impact on the market.

Tag: Eli Lilly

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.